{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:45:00Z","timestamp":1791024300594,"version":"4.1.0"},"reference-count":184,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T00:00:00Z","timestamp":1149638400000},"content-version":"vor","delay-in-days":736,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Drug Reviews"],"published-print":{"date-parts":[[2004,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>This paper reviews the pharmacology and toxicology of 3,4\u2010methylenedioxy\u2010N\u2010ethyl\u2010amphetamine (MDEA, \u201ceve\u201d). MDEA is a ring\u2010substituted amphetamine (RSA) like MDMA, its well known N\u2010methyl analog. Both have become very popular substances of abuse in the techno\u2010 and house\u2010music scene. They can evoke psychomotor stimulation, mild alterations of perception, sensations of closeness and a positive emotional state as well as sympathomimetic physical effects. At present, the name \u201cecstasy\u201d is no longer used only for MDMA, but for the whole group of RSAs (MDA, MDMA, MDEA and MBDB) as they are chemically and pharmacologically nearly identical; moreover, many ecstasy pills contain mixtures of the RSAs. Hence, for a selective review on MDEA, it is crucial to strictly differentiate between: 1) street and chemical names, and 2) studies with or without chemically defined substances. In order to present MDEA\u2010specific information, the pharmacodynamics and kinetics are described on the basis of MDEA challenge studies in animals and humans. In the toxicology section, we present a collection of case reports on fatalities where MDEA was toxicologically confirmed. On the question of serotonergic neurotoxicity and possible long\u2010term consequences, however, MDEA\u2010specific information is available from animal studies only. The neurotoxic potential of MDEA in humans is difficult to estimate, as ecstasy users do not consume pure substances. For future research, challenge studies in animals using dosing regimens adapted to human consumption patterns are needed. Such challenge studies should directly compare individual RSAs. They will represent the most viable and fruitful approach to the resolution of the highly controversial issues of serotonergic neurotoxicity and its functional consequences.<\/jats:p>","DOI":"10.1111\/j.1527-3458.2004.tb00007.x","type":"journal-article","created":{"date-parts":[[2010,8,14]],"date-time":"2010-08-14T00:28:32Z","timestamp":1281745712000},"page":"89-116","source":"Crossref","is-referenced-by-count":30,"title":["The Neuropsychopharmacology and Toxicology of 3,4\u2010methylenedioxy\u2010N\u2010ethyl\u2010amphetamine (MDEA)"],"prefix":"10.1111","volume":"10","author":[{"given":"Roland W.","family":"Freudenmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,6,7]]},"reference":[{"key":"e_1_2_2_2_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A447"},{"key":"e_1_2_2_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000433-199806000-00009"},{"key":"e_1_2_2_4_2","unstructured":"BakerR BowersM.Ritonavir and ecstasy.Beta1997;March:5."},{"key":"e_1_2_2_5_2","first-page":"718","article-title":"Intoxicaci\u00f3n aguda mortal por metilendioxianfetamina (cited after Arimany et al. 1998)","volume":"106","author":"Balanz\u00f3 X","year":"1996","journal-title":"Med Clin (Barc)"},{"key":"e_1_2_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(99)00170-7"},{"key":"e_1_2_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90056-8"},{"key":"e_1_2_2_8_2","first-page":"240","article-title":"Pharmacologic profile of amphetamine derivatives at various brain recognition sites: Selective effects on serotonergic systems","volume":"94","author":"Battaglia G","year":"1989","journal-title":"NIDA Res Monogr"},{"key":"e_1_2_2_9_2","first-page":"95","volume-title":"Jahrbuch f\u00fcr Ethnomedizin und Bewu\u03b2tseinsforschung 1997\/98","author":"Beck C","year":"2000"},{"key":"e_1_2_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-1485-1_6"},{"key":"e_1_2_2_11_2","doi-asserted-by":"publisher","DOI":"10.1039\/b005662f"},{"key":"e_1_2_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/21.1.59"},{"key":"e_1_2_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(87)90206-1"},{"key":"e_1_2_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90277-W"},{"key":"e_1_2_2_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.4.409-a"},{"key":"e_1_2_2_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600690220"},{"key":"e_1_2_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)00404-7"},{"key":"e_1_2_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(98)00396-X"},{"key":"e_1_2_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/95.7.475"},{"key":"e_1_2_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4274(99)00205-2"},{"key":"e_1_2_2_21_2","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/clinchem\/46.12.1968","article-title":"Determination of the designer drugs 3,4\u2010methylenedioxymethamphetamine, 3,4\u2010methylenedioxyethylamphetamine, and 3,4\u2010methylenedioxyamphetamine with HPLC and fluorescence detection in whole blood, serum, vitreous humor, and urine","volume":"46","author":"Clauwaert KM","year":"2000","journal-title":"Clin Chem"},{"key":"e_1_2_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)02305-1"},{"key":"e_1_2_2_23_2","doi-asserted-by":"publisher","DOI":"10.2190\/DCRP-U22M-AUMD-D84H"},{"key":"e_1_2_2_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1999.tb01492.x"},{"key":"e_1_2_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701201"},{"key":"e_1_2_2_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00222.x"},{"key":"e_1_2_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0379-0738(95)01846-8"},{"key":"e_1_2_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701325"},{"key":"e_1_2_2_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1997.tb02951.x"},{"key":"e_1_2_2_30_2","first-page":"54","article-title":"[Epidemiology of designer drug use in Spain]","volume":"108","author":"Fuente de Hoz L","year":"1997","journal-title":"Med Clin (Barc)"},{"key":"e_1_2_2_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00121.x"},{"key":"e_1_2_2_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb05199.x"},{"key":"e_1_2_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)75653-1"},{"key":"e_1_2_2_34_2","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.1987.03390120077027","article-title":"\u2018Eve\u2019 and \u2018Ecstasy\u2019. A report of five deaths associated with the use of MDEA and MDMA","volume":"257","author":"Dowling GP","year":"1987","journal-title":"JAMA"},{"key":"e_1_2_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(96)00129-6"},{"key":"e_1_2_2_36_2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0090-9556(25)07439-2","article-title":"Metabolism of racemic 3,4\u2010methylenedioxyethylamphetamine in humans. Isolation, identification, quantification, and synthesis of urinary metabolites","volume":"24","author":"Ensslin HK","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(99)00095-X"},{"key":"e_1_2_2_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01369826"},{"key":"e_1_2_2_39_2","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1523\/JNEUROSCI.15-08-05476.1995","article-title":"Reorganization of ascending 5\u2010HT axon projections in animals previously exposed to the recreational drug (+\/\u2010) 3,4\u2010methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d)","volume":"15","author":"Fischer C","year":"1995","journal-title":"J Neurosci"},{"key":"e_1_2_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0379-0738(94)90242-9"},{"key":"e_1_2_2_41_2","doi-asserted-by":"publisher","DOI":"10.1211\/0022357011777855"},{"key":"e_1_2_2_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704502"},{"key":"e_1_2_2_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1997.tb02850.x"},{"key":"e_1_2_2_44_2","first-page":"510","article-title":"[Ecstasy \u2013 the status in French\u2010speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity]","volume":"86","author":"Giroud C","year":"1997","journal-title":"Schweiz Rundsch Med Prax"},{"key":"e_1_2_2_45_2","first-page":"154","article-title":"Phenylalkylamine stimulants, hallucinogens, and designer drugs","volume":"105","author":"Glennon RA","year":"1991","journal-title":"NIDA Res Monogr"},{"key":"e_1_2_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(89)90491-7"},{"key":"e_1_2_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(00)00174-X"},{"key":"e_1_2_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(88)90001-9"},{"key":"e_1_2_2_49_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820130081018"},{"key":"e_1_2_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(92)90191-2"},{"key":"e_1_2_2_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.1993.20"},{"key":"e_1_2_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(01)01306-3"},{"key":"e_1_2_2_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00115-001-1243-6"},{"key":"e_1_2_2_54_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.6.719"},{"key":"e_1_2_2_55_2","first-page":"369","article-title":"Die Entaktogene \u201cEcstasy\u201d (MDMA), \u201cEve\u201d (MDE) und andere ringsubstituierte Methamphetaminderivate. Eine neue Stoffklasse unter den illegalen Designerdrogen","volume":"67","author":"Gouzoulis\u2010Mayfrank E","year":"1996","journal-title":"Nervenarzt"},{"key":"e_1_2_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(98)00089-X"},{"key":"e_1_2_2_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050860"},{"key":"e_1_2_2_58_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.55.3.3"},{"key":"e_1_2_2_59_2","first-page":"57","article-title":"Using MDMA in psychotherapy","volume":"2","author":"Greer G","year":"1985","journal-title":"Advances"},{"key":"e_1_2_2_60_2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1176\/appi.psychotherapy.1986.40.3.393","article-title":"Can drugs be used to enhance the psychotherapeutic process","volume":"40","author":"Grinspoon L","year":"1986","journal-title":"Am J Psychother"},{"key":"e_1_2_2_61_2","first-page":"55","article-title":"Neuropharmacology and neurotoxicity of 3,4\u2010methylenedioxymethamphetamine","volume":"79","author":"Gudelsky GA","year":"2003","journal-title":"Methods Mol Med"},{"key":"e_1_2_2_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1131-1"},{"key":"e_1_2_2_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.10055"},{"key":"e_1_2_2_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(98)00046-3"},{"key":"e_1_2_2_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/1056-8719(95)00045-J"},{"key":"e_1_2_2_66_2","doi-asserted-by":"publisher","DOI":"10.1520\/JFS11976J"},{"key":"e_1_2_2_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79824-X"},{"key":"e_1_2_2_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91469-O"},{"key":"e_1_2_2_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.1993.19"},{"key":"e_1_2_2_70_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01285547"},{"key":"e_1_2_2_71_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563659609013778"},{"key":"e_1_2_2_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00111-2"},{"key":"e_1_2_2_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(87)90565-X"},{"key":"e_1_2_2_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(89)90534-0"},{"key":"e_1_2_2_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90615-1"},{"key":"e_1_2_2_76_2","volume-title":"Monitoring the Future national survey results on drug use, 1975\u20132002","author":"Johnston LD","year":"2003"},{"key":"e_1_2_2_77_2","volume-title":"Monitoring the Future national survey results on drug use, 1975\u20132002","author":"Johnston LD","year":"2003"},{"key":"e_1_2_2_78_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.18-06-01979.1998"},{"key":"e_1_2_2_79_2","first-page":"917","article-title":"The pharmacology and toxicology of \u201cecstasy\u201d (MDMA) and related drugs","volume":"165","author":"Kalant H","year":"2001","journal-title":"Can Med Assoc J"},{"key":"e_1_2_2_80_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.3.411a"},{"key":"e_1_2_2_81_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704961"},{"key":"e_1_2_2_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(01)00708-0"},{"key":"e_1_2_2_83_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200204000-00009"},{"key":"e_1_2_2_84_2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.npp.1395211","article-title":"Characterization of the translocation of protein kinase C (PKC) by 3,4\u2010methylenedioxymethamphetamine (MDMA\/ecstasy) in synaptosomes: Evidence for a presynaptic localization involving the serotonin transporter (SERT)","volume":"19","author":"Kramer HK","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"e_1_2_2_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(00)00284-7"},{"key":"e_1_2_2_86_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/14.3.149"},{"key":"e_1_2_2_87_2","first-page":"36552","article-title":"Schedules of Controlled Substances; Scheduling of 3,4\u2010methylenedioxymethamphetamine (MDMA) into Schedule I of the Controlled Substance Act","volume":"51","author":"Lawn JC","year":"1986","journal-title":"Federal Register"},{"key":"e_1_2_2_88_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/25.6.471"},{"key":"e_1_2_2_89_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.1994.26"},{"key":"e_1_2_2_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(99)00148-7"},{"key":"e_1_2_2_91_2","doi-asserted-by":"publisher","DOI":"10.1021\/tx00006a008"},{"key":"e_1_2_2_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90717-0"},{"key":"e_1_2_2_93_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/26.5.267"},{"key":"e_1_2_2_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(96)02095-6"},{"key":"e_1_2_2_95_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00178519"},{"key":"e_1_2_2_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(89)90746-2"},{"key":"e_1_2_2_97_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/22.1.33"},{"key":"e_1_2_2_98_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199608000-00027"},{"key":"e_1_2_2_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4274(99)00207-6"},{"key":"e_1_2_2_100_2","first-page":"109","article-title":"Zum Metabolismus von 3,4\u2010Methylendioxyetilampfetamin (MDEA) beim Menschen","volume":"38","author":"Maurer HH","year":"1992","journal-title":"Sucht"},{"key":"e_1_2_2_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)02423-X"},{"key":"e_1_2_2_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(91)90005-M"},{"key":"e_1_2_2_103_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1990.tb13277.x"},{"key":"e_1_2_2_104_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(02)00776-0"},{"key":"e_1_2_2_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(02)00821-2"},{"key":"e_1_2_2_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0270(93)90056-W"},{"key":"e_1_2_2_107_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.49.2.149"},{"key":"e_1_2_2_108_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200204000-00003"},{"key":"e_1_2_2_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(97)00573-2"},{"key":"e_1_2_2_110_2","doi-asserted-by":"publisher","DOI":"10.1080\/hrp.10.4.212.220"},{"key":"e_1_2_2_111_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000545"},{"key":"e_1_2_2_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-328X(99)00178-3"},{"key":"e_1_2_2_113_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00444689"},{"key":"e_1_2_2_114_2","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1986.10472362"},{"key":"e_1_2_2_115_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00347a010"},{"key":"e_1_2_2_116_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-1485-1_7"},{"key":"e_1_2_2_117_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1990.tb16914.x"},{"key":"e_1_2_2_118_2","first-page":"1","volume-title":"Moderne Suchtmedizin","author":"Nowoczyn N","year":"1998"},{"key":"e_1_2_2_119_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00212770"},{"key":"e_1_2_2_120_2","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0022-3565(25)22947-0","article-title":"(+)\u2010N\u2010methyl\u20101\u2013(1,3\u2010benzodioxol\u20105\u2010yl)\u20102\u2010butanamine as a discriminative stimulus in studies of 3,4\u2010methylenedioxy\u2010methamphetamine\u2010like behavioral activity","volume":"255","author":"Oberlender R","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_2_121_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-001-0041-y"},{"key":"e_1_2_2_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(00)00179-2"},{"key":"e_1_2_2_123_2","doi-asserted-by":"publisher","DOI":"10.1002\/hup.351"},{"key":"e_1_2_2_124_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(01)00711-0"},{"key":"e_1_2_2_125_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050714"},{"key":"e_1_2_2_126_2","first-page":"15","article-title":"The effects of MDMA and other methylenedioxy\u2010substituted phenylalkylamines on the structure of rat locomotor activity","volume":"7","author":"Paulus MP","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"e_1_2_2_127_2","first-page":"273","article-title":"Subjective effects of 3,4\u2010methylenedioxymethamphetamine in recreational users","volume":"1","author":"Peroutka SJ","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"e_1_2_2_128_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-1485-1"},{"key":"e_1_2_2_129_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(88)90658-1"},{"key":"e_1_2_2_130_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(97)88056-5"},{"key":"e_1_2_2_131_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(02)00151-2"},{"key":"e_1_2_2_132_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200108000-00003"},{"key":"e_1_2_2_133_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(02)01028-6"},{"key":"e_1_2_2_134_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.4023719"},{"key":"e_1_2_2_135_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(87)90233-0"},{"key":"e_1_2_2_136_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1992.tb24586.x"},{"key":"e_1_2_2_137_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06880-5"},{"key":"e_1_2_2_138_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4274(99)00216-7"},{"key":"e_1_2_2_139_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1074501"},{"key":"e_1_2_2_140_2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0272-2712(18)30148-3","article-title":"Recreational drugs. Current trends in the 90s","volume":"18","author":"Ropero\u2010Miller JD","year":"1998","journal-title":"Clin Lab Med"},{"key":"e_1_2_2_141_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(02)00234-6"},{"key":"e_1_2_2_142_2","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3"},{"key":"e_1_2_2_143_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/12.4.229"},{"key":"e_1_2_2_144_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00441948"},{"key":"e_1_2_2_145_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-199608000-00002"},{"key":"e_1_2_2_146_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7054.423a"},{"key":"e_1_2_2_147_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(87)90474-6"},{"key":"e_1_2_2_148_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(88)90390-5"},{"key":"e_1_2_2_149_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-3623(91)90226-V"},{"key":"e_1_2_2_150_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01473-8"},{"key":"e_1_2_2_151_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(87)90782-5"},{"key":"e_1_2_2_152_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90154-9"},{"key":"e_1_2_2_153_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(90)90254-4"},{"key":"e_1_2_2_154_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(02)00823-6"},{"key":"e_1_2_2_155_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050497"},{"key":"e_1_2_2_156_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)75654-3"},{"key":"e_1_2_2_157_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1994.1112"},{"key":"e_1_2_2_158_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.63.6.1223"},{"key":"e_1_2_2_159_2","volume-title":"PiKHAL. A chemical love story","author":"Shulgin A","year":"1991"},{"key":"e_1_2_2_160_2","first-page":"243","volume-title":"Handbook of psychopharmacology","author":"Shulgin AT","year":"1978"},{"key":"e_1_2_2_161_2","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.1986.10472361"},{"key":"e_1_2_2_162_2","first-page":"74","volume-title":"The psychopharmacology of hallucinogenes","author":"Shulgin AT","year":"1978"},{"key":"e_1_2_2_163_2","doi-asserted-by":"publisher","DOI":"10.1038\/221537a0"},{"key":"e_1_2_2_164_2","first-page":"2248","article-title":"[Designer drugs in Jutland]","volume":"163","author":"Simonsen KW","year":"2001","journal-title":"Ugeskr Laeger"},{"key":"e_1_2_2_165_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563658708992620"},{"key":"e_1_2_2_166_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(99)00195-4"},{"key":"e_1_2_2_167_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(01)00060-0"},{"key":"e_1_2_2_168_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.6.705"},{"key":"e_1_2_2_169_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(87)90173-7"},{"key":"e_1_2_2_170_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90555-8"},{"key":"e_1_2_2_171_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/26.5.253"},{"key":"e_1_2_2_172_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1993.tb03181.x"},{"key":"e_1_2_2_173_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1993.tb07072.x"},{"key":"e_1_2_2_174_2","doi-asserted-by":"publisher","DOI":"10.1159\/000050709"},{"key":"e_1_2_2_175_2","first-page":"241","article-title":"MDEA related death in Crete: A case report and literature review","volume":"39","author":"Tsatsakis AM","year":"1997","journal-title":"Vet Hum Toxicol"},{"key":"e_1_2_2_176_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(94)90386-7"},{"key":"e_1_2_2_177_2","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2001.10400473"},{"key":"e_1_2_2_178_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001010050650"},{"key":"e_1_2_2_179_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(97)00185-0"},{"key":"e_1_2_2_180_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)00774-K"},{"key":"e_1_2_2_181_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00215-5"},{"key":"e_1_2_2_182_2","first-page":"6","volume-title":"Amphetamine like stimulants","author":"World Health Organization","year":"1996"},{"key":"e_1_2_2_183_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(97)00014-2"},{"key":"e_1_2_2_184_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/25.4.258"},{"key":"e_1_2_2_185_2","doi-asserted-by":"publisher","DOI":"10.1080\/1071576031000076286"}],"container-title":["CNS Drug Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1527-3458.2004.tb00007.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1527-3458.2004.tb00007.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T12:52:41Z","timestamp":1740401561000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1527-3458.2004.tb00007.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":184,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["10.1111\/j.1527-3458.2004.tb00007.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1527-3458.2004.tb00007.x","archive":["Portico"],"relation":{},"ISSN":["1080-563X","1527-3458"],"issn-type":[{"value":"1080-563X","type":"print"},{"value":"1527-3458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}